US Life Sciences Investment Dips But Main Hubs Dodge Headwinds: Report
October 10, 2022
Article by: Anna Staropoli
Venture capital funding dropped 18.5 percent this year and now hovers at $20.8 billion after the first half of 2022, Newmark says. Despite the short-term decline, this number remains higher than every full year prior to 2018.
Read the full article: https://bit.ly/3RJBwZK